Clinical outcomes and molecular epidemiology of vancomycin-resistant Enterococcus faecium bloodstream infection: The importance of appropriate therapy and ST17 predominance

Chih-Chieh Hsu; Chiau-Jing Jung; Jia-Ling Yang; Chi-Ying Lin; Sung-Hsi Huang; Jann-Tay Wang; Yu-Chung Chuang

doi:10.1016/j.jiph.2026.103274

Q1 2026

Clinical outcomes and molecular epidemiology of vancomycin-resistant Enterococcus faecium bloodstream infection: The importance of appropriate therapy and ST17 predominance

Chih-Chieh Hsu · Chiau-Jing Jung · Jia-Ling Yang · Chi-Ying Lin · Sung-Hsi Huang · Jann-Tay Wang · Yu-Chung Chuang

10.1016/j.jiph.2026.103274 387 Views 1 Citations

Citations

387

Views

Abstract not available for this publication.

Cite this Article (APA)

Chih-Chieh, H., Chiau-Jing, J., Jia-Ling, Y., Chi-Ying, L., Sung-Hsi, H., Jann-Tay, W., Yu-Chung, C. (2026). Clinical outcomes and molecular epidemiology of vancomycin-resistant Enterococcus faecium bloodstream infection: The importance of appropriate therapy and ST17 predominance. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2026.103274